Key result
Thyrotoxic periodic paralysis is a potentially lethal complication of hyperthyroidism affecting mainly young Asian men, which can be acutely managed with potassium supplementation and non-selective beta blockers.
Potassium supplementation and non-selective beta-blockers are the mainstays of treatment for thyrotoxic periodic paralysis to abort attacks and prevent life-threatening arrhythmias.
Answers are grounded in this paper and cite their sources.
Prompts consideration of thyrotoxic periodic paralysis in hyperthyroid Asian men with paralysis; leaves open optimal long-term prevention strategies.
Thyrotoxic Periodic Paralysis (TPP) is a potentially lethal manifestation of hyperthyroidism which is characterized by hypokalemia and muscular weakness. It mainly affects Asian men in the age group of 20 to 40 years. Immediate supplementation with oral or intravenous potassium will help to not only abort the acute attack of paralysis but will also prevent serious and life threatening cardiac arrhythmias. Non selective beta blockers like propranolol can also be used to ameliorate and prevent subsequent paralytic attack. Acetazolamide has no role in the treatment of TPP.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2015) conducted a review in Thyrotoxic Periodic Paralysis. Potassium and non-selective beta blockers was evaluated. Thyrotoxic periodic paralysis is a potentially lethal complication of hyperthyroidism affecting mainly young Asian men, which can be acutely managed with potassium supplementation and non-selective beta blockers.
Synapse has enriched 10 related papers. Consider them for comparative context: